Y-Biologics, Inc. (KOSDAQ:338840)
South Korea
· Delayed Price · Currency is KRW
11,450
+380 (3.43%)
At close: Aug 13, 2025, 3:30 PM KST
Y-Biologics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Aug '25 Aug 15, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 167,879 | 113,678 | 230,299 | - | - | - | |
| Market Cap Growth | -52.33% | -50.64% | - | - | - | - | |
| Enterprise Value | 159,195 | 102,035 | 230,749 | - | - | - | |
| Last Close Price | 11230.00 | 7690.00 | 15600.00 | - | - | - | |
| PS Ratio | 33.39 | 19.73 | 66.19 | - | - | - | |
| PB Ratio | 9.52 | 5.79 | 8.86 | - | - | - | |
| P/TBV Ratio | 10.18 | 6.27 | 9.94 | - | - | - | |
| EV/Sales Ratio | 31.67 | 17.71 | 66.33 | - | - | - | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.11 | 0.25 | 0.21 | 0.16 | |
| Asset Turnover | 0.22 | 0.22 | 0.12 | 0.12 | 0.11 | 0.16 | |
| Quick Ratio | 8.07 | 10.58 | 7.39 | 1.60 | 2.91 | 3.35 | |
| Current Ratio | 8.28 | 10.73 | 7.48 | 1.70 | 3.20 | 3.78 | |
| Return on Equity (ROE) | -31.88% | -28.23% | -90.84% | -77.73% | -54.50% | -40.90% | |
| Return on Assets (ROA) | -22.16% | -20.30% | -21.27% | -34.84% | -24.67% | -11.53% | |
| Return on Capital (ROIC) | -23.69% | -21.41% | -23.57% | -39.71% | -29.35% | -16.78% | |
| Earnings Yield | -3.99% | -5.67% | -9.06% | - | - | - | |
| FCF Yield | -4.30% | -6.16% | -3.39% | - | - | - | |
| Buyback Yield / Dilution | -12.40% | -19.30% | -1.87% | -1.01% | -21.93% | -5.25% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.